Ali Khademhosseini
Terasaki Institute for Biomedical Innovation, USA

Ali Khademhosseini is the CEO and Founding Director of the Terasaki Institute for Biomedical Innovation. He is also a Researcher for Amazon Web Services Inc. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles. He joined UCLA as the Levi Knight Chair starting November 2017. In Harvard University, he was a Professor at the Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology, Brigham and Women’s Hospital and an associate faculty at the Wyss Institute for Biologically Inspired Engineering. He is recognized as a leader in combining micro and nano-engineering approaches with advanced biomaterials for regenerative medicine applications. Particularly, his laboratory has pioneered numerous technologies and materials for controlling the architecture and function of engineered vascularized tissues. He has authored >650 journal papers (H-index > 128, >61,300 citations) and 70 books/chapters. In addition, he has delivered 300+ lectures. Dr. Khademhosseini’s interdisciplinary research has been recognized by over 60 national and international awards. Currently he serves on the editorial board of numerous leading journals. He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering.